🇺🇸 FDA
Patent

US 9962385

Methods and compositions for treating abnormal cell growth

granted A61KA61K31/4184A61K31/437

Quick answer

US patent 9962385 (Methods and compositions for treating abnormal cell growth) held by VERASTEM, INC. expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4184, A61K31/437, A61K31/44, A61K31/4523